After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.
Read all about it on the Communication page by clicking this link: Communications
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
We have now added a new section called the "Assay History List" to the "At A Gla...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...